Apparatus for assaying viscosity changes in fluid samples and method of conducting same

• US 5,447,440 A
• Filed: 10/28/1993
• Issued: 09/05/1995
• Est. Priority Date: 10/28/1993
• Status: Expired due to Term

• Current Assignee: Abbott Point Of Care Incorporated (Abbott Laboratories)
• Original Assignee: i STAT Corporation (Abbott Laboratories)
• Inventors: Davis, Graham, Zelin, Michael P., Lauks, Imants R.
• Primary Examiner(s): Redding, David A.
• Application Number:
  US08/142,130
• Time in Patent Office: 677 Days
• Field of Search: 422/73, 422/82.02, 422/82.05, 436/66, 436/69, 436/50, 436/55, 436/63, 436/86, 436/87, 436/91, 436/92, 436/93, 436/94, 436/150, 436/165, 436/805, 436/806, 436/807, 436/816, 436/827, 436/828, 436/901, 436/501 , 436/517, 436/539, 73/54.04, 73/54.07, 73/64.41, 73/64.43, 435/13, 435/6, 435/7.1, 435/7.4, 435/7.91, 435/289, 435/291, 435/960, 435/975
• US Class Current: 435/6.16
• CPC Class Codes: G01N 11/04 through a restricted passage, e.g. tube, aperture
• CPC Class Codes: G01N 2474/20 Immunohistochemistry assay
• CPC Class Codes: G01N 33/4905 Determining clotting time of blood by chemical methods G01N33/86, C12Q1/56
• CPC Class Codes: Y10S 435/975 Kit
• CPC Class Codes: Y10S 436/806 Electrical property or magnetic property
• CPC Class Codes: Y10S 436/807 Apparatus included in process claim, e.g. physical support structures
• CPC Class Codes: Y10S 436/816 Alkaloids, amphetamines, and barbiturates
• CPC Class Codes: Y10S 436/901 Drugs of abuse, e.g. narcotics, amphetamine
• CPC Class Codes: Y10T 436/115831 Condition or time responsive
• CPC Class Codes: Y10T 436/12 Condition responsive control
• CPC Class Codes: Y10T 436/14 Heterocyclic carbon compound [i.e. , O, S, N, Se, Te, as only ring hetero atom]
• CPC Class Codes: Y10T 436/141111 Diverse hetero atoms in same or different rings [e.g., alkaloids, opiates, etc.]
• CPC Class Codes: Y10T 436/143333 Saccharide [e.g., DNA, etc.]

Abstract

The present invention relates to an apparatus for conducting a variety of assays that are responsive to a change in the viscosity of a sample fluid and relates to methods of conducting such assays. In particular, the present invention is related to the use of a cartridge for conducting one or more coagulation assays or, conversely, fibrinolysis assays. The disclosed device enjoys simplicity and is adaptable to the point-of-care clinical diagnostic area, including use in accident sites, emergency rooms, surgery or intensive care units.

Claims

1. A method of measuring a change in the viscosity of a fluid sample comprising:

(a) charging a housing adapted for insertion into an external reading device with a fluid sample, said housing (i) equipped with sample displacement means for applying a force against said fluid sample effective to displace at least a portion of said fluid sample within said housing, (ii) contained within said housing, at least one reagent capable after contact with said fluid sample of promoting a change in the viscosity of said fluid sample, and (iii) contained within said housing, at least one sensing means capable of detecting the displacement of said fluid sample;

(b) applying said force to said fluid sample, such that said reagent comes into contact with said fluid sample and at least a portion of said fluid sample is displaced across said sensing means;

(c) detecting changes through said sensing means, in the displacement of said fluid sample, which changes are a measure of the change in the viscosity of said fluid sample.

2. The method of claim 1 in which said sample displacement means comprises a pump means.

3. The method of claim 1 in which said force is applied reversibly, such that at least a portion of said fluid sample is displaced back and forth across said sensing means in a substantially reciprocating manner.

4. The method of claim 1 in which said measurement is applied to a test selected from the group consisting of prothrombin time (PT), partial thromboplastin time (PTT), activated partial thromboplastin time (APTT), thrombin clotting time (TCT), activated clotting time (ACT), and fibrinogen assay.

5. The method of claim 1 in which said changes in the displacement of said fluid sample are relayed to the external reading device.

6. The method of claim 2 in which said changes in the displacement of said fluid sample are relayed to the external reading device equipped with a plunger that engages said pump means for displacing said fluid sample across said sensing means in a substantially reciprocating manner, said plunger being actuated by said reading device in response to the output of said sensing means.

7. The method of claim 1 in which said fluid sample is blood or plasma.

8. The method of claim 1 in which said measurement is applied to an immunoassay or affinity-based assay responsive to a change in the viscosity of said fluid sample.

9. The method of claim 8 in which said assay tests for the presence of a drug substance.

10. The method of claim 9 in which said drug substance is a therapeutic agent or substance of abuse.

11. The method of claim 9 in which said drug substance is selected from the group consisting of theophylline, digoxin, phenytoin, thyroxins, cocaine and amphetamines.

12. The method of claim 8 in which said assay tests for the presence of a peptide, an oligo peptide or a polypeptide.

13. The method of claim 8 in which said assay tests for the presence of a nucleotide, oligonucleotide or polynucleotide.

14. The method of claim 8 in which said assay tests for the presence of a sugar, oligosaccharide or polysaccharide.

15. The method of claim 2 in which said pump means comprises a resilient diaphragm.

16. The method of claim 6 in which a feedback method relates said output of said sensing means to said actuation of said plunger.

17. The method of claim 1 in which said sensing means is capable of sensing the fluid sample displacement oscillation frequency, amplitude or changes therein.

18. The method of claim 17 in which said frequency, amplitude or changes therein are reflected in the output of said sensing means as a function of time.

19. The method of claim 1 in which said sensing means comprises a conductivity sensor.

20. The method of claim 19 in which said sensor is arranged in a parallel configuration.

21. The method of claim 19 in which said sensor is arranged in an orthogonal configuration.

22. The method of claim 1 in which said measurement is applied to an agglutination test.

23. The method of claim 4 in which said reagent includes a reagent for a PT test.

24. The method of claim 4 in which said reagent includes a reagent for a PTT test.

25. The method of claim 4 in which said reagent includes a reagent for an APTT test.

26. The method of claim 4 in which said reagent includes a reagent for a TCT test.

27. The method of claim 4 in which said reagent includes a reagent for an ACT test.

28. The method of claim 4 in which said reagent includes a reagent for a fibrinogen assay.

29. The method of claim 8 in which said reagent includes a reagent for an agglutination immunoassay.

30. The method of claim 22 in which said reagent includes a reagent for an agglutination test.

31. A method of conducting a blood fibrinolysis test comprising:

(a) charging a housing adapted for insertion into an external reading device with a blood sample, said housing (i) equipped with sample displacement means for applying force against said blood sample effective to displace at least a portion of said blood sample within said housing, (ii) contained within said housing, at least one reagent capable after contact with said blood sample of promoting the coagulation of said blood sample, and (iii) contained within said housing, at least one sensing means capable of detecting the displacement of said blood sample;

(b) applying said force to said blood sample, such that said reagent comes into contact with said blood sample and at least a portion of said blood sample is displaced across said sensing means;

(c) detecting changes, through said sensing means, in the displacement of said blood sample as a measure of the coagulation of said blood sample;

(d) maintaining said force against said coagulated blood sample until lytic processes cause said coagulated blood sample to become less viscous, allowing increased displacement of at least a portion of said lysed blood sample across said sensing means.

32. The method of claim 31 which further comprises treating said coagulated blood sample with a second reagent capable of promoting the fibrinolysis of said coagulated blood sample.

33. The method of claim 32, in which said second reagent is selected from the group consisting of tissue plasminogen activator (tPA), streptokinase or urokinase.

34. The method of claim 32 in which the results of separate fibrinolysis tests, each using separate second reagents, are compared to determine the most efficacious reagent.